Pfizer Limited - Due diligence report

A 360° intelligence report on Pfizer: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…

1950-11-21 Mumbai, Maharashtra Active Listed Active Compliant
Share
View plans Plan
PL Pfizer Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pfizer — 360° Intelligence Report

Generated from MCA filings & public records
73/100
Trust Score
Moderate

Pfizer is assessed as Moderate with a Trust Score of 73/100. Pfizer is an active public limited indian non-government company incorporated in 1950, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 06 Jul 2026 from the latest processed filings. Pfizer Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
42/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 42/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: SEBI, CDSL, NSDL.
  • Litigation present in 3 court forum(s).
  • Delayed payments to MSME suppliers disclosed (14 disclosure(s)).
  • 21 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 80/100
NameDIN / PANDesignationAppointedTenureDIN status
MEENA GANESH 01234567 Director 01/04/2018 6 yrs Approved
PRADIP PANALAL SHAH 01234567 Director 01/04/2018 6 yrs Approved
PRAJEET NAIR 01234567 Director 01/04/2018 6 yrs Approved
Pazhania Pillai Rengan 01234567 Director 01/04/2018 6 yrs Approved
Amit Agarwal 01234567 Director 01/04/2018 6 yrs Approved
PRAJEET NAIR 01234567 Director 01/04/2018 6 yrs Approved
SONIA SINGH 01234567 Director 01/04/2018 6 yrs Approved
MEENAKSHI NEVATIA 01234567 Director 01/04/2018 6 yrs Approved
LAKSHMANAN KRISHNA KUMAR 01234567 Director 01/04/2018 6 yrs Approved
Amit Agarwal 01234567 Director 01/04/2018 6 yrs Approved
  • 10 directors on the board.
  • No disqualified or deactivated DINs.
  • 5 director exits in 3 years - high churn.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 3 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Key managerial personnel: Pazhania Pillai Rengan (Whole-time director) · Amit Agarwal (CFO) · MEENAKSHI NEVATIA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 80
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Net margin improved to 1.42.
Operating for 75+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 director exits within 2 years.
Compliance score is weak (42/100).
MSME payment delays disclosed - latest outstanding 1.42 cr.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence63/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
21 Jul 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 Nov 2024
Director ceased
PRADIP PANALAL SHAH
27 Aug 2024
Director ceased
SONIA SINGH
Director ceased
LAKSHMANAN KRISHNA KUMAR
29 Jul 2024
Director appointed
SONIA SINGH (Director)
Director appointed
LAKSHMANAN KRISHNA KUMAR (Director)
07 Mar 2024
Director appointed
Amit Agarwal (Cfo)
26 Feb 2024
Director appointed
Amit Agarwal (CFO)
Director ceased
Amit Agarwal
06 Jan 2024
Director appointed
Pazhania Pillai Rengan (Whole-time director)
28 Oct 2023
Director ceased
Pazhania Pillai Rengan
03 Apr 2023
Director appointed
MEENAKSHI NEVATIA (Managing Director)
Director ceased
MEENAKSHI NEVATIA
31 Mar 2022
Share transfer (FY 2022)
35.00000000 shares to ARCHANA KAPADIA
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
21 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Salubrity Biotech Limited L24100WB1990PLC048591 Kolkata, West Bengal, India
Fine Organics L24119MH2002PLC136003 Mumbai, Maharashtra, India
Chemplast Sanmar L24230TN1985PLC011637 Madras, Tamil Nadu, India
Glenmark Life Sciences L74900PN2011PLC139963 Solapur, Maharashtra, India
Biocon L24234KA1978PLC003417 Bengaluru, Karnataka, India
Linde India L40200WB1935PLC008184 Kolkata, West Bengal, India
Sudarshan L24119PN1951PLC008409 Pune, Maharashtra, India
Meghmani L24100GJ2007PLC051717 Ahmadabad City, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pfizer before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pfizer: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Pfizer - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Pfizer pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Pfizer - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pfizer an active company?

Pfizer has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).

Is Pfizer financially healthy?

Pfizer has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Pfizer?

Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pfizer?

Promoters hold a minority stake - exact percentages are in the full report. 10 active director(s) are on record.

Does Pfizer have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Pfizer up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).

Is it risky to lend to Pfizer?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.